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The proteome is far more complex than it was ever expected at the 
genesis of the proteomics revolution. Dynamics in time, space and 
concentration as well as variability due to modifications and mutations 
require novel and complementary approaches to generate useful, reliable 
and complete information. As it turns out, there is no single platform able to 
unravel the proteome in its full complexity. 
Here we present a multi-tier approach to turn proteomic data into 
knowledge based on the combination of LC- MALDI-TOF and LC-ESI based 
technology for identification, quantification, characterization and localization 
of proteins combined with software tools for integration of different 
technology platforms allowing querying and reporting according to generally 
accepted guidelines. 
The data presented covers top-down as well as bottom-up analysis and 
shows ways to increase the proteome coverage in terms of identified 
peptides and their inferred proteins. Further information is obtained by the 
characterization of the proteins regarding their posttranslational 
modifications such as phosphorylation or glycosylation. We will also 
describe new tools for the comprehensive analysis of glycans and 
glycopeptides parallel to unmodified peptides. We will demonstrate how 
quantitative information using labelfree as well as label-based approaches 
can be obtained and turned into comparative data for in-depth sample 
analysis. As MALDI-TOF also allows for obtaining spatially resolved 
information directly from tissue, we will show an example for a workflow 
where differences between different cancer types had been identified using 
MALDI-TOF imaging in combination with statistical analysis and subsequent 
identification of a protein cancer biomarker could be obtained using ETD ion 
trap tandem mass spectrometry. 
 
